Biotechne share price

Author: yfjo

August undefined, 2024

WebApr 10, 2024 · The 12-month stock price forecast is $103.14, which is an increase of 32.57% from the latest price. Price Target. $103.14 (32.57% upside) Analyst … WebDec 31, 2024 · Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell …

Bio-Techne Releases Fourth Quarter Fiscal 2024 Results :: Bio-Techne ...

WebApr 10, 2024 · Summary of all time highs, changes and price drops for Bio-Techne; Historical stock prices; Current Share Price: US$75.19: 52 Week High: US$108.19: 52 Week Low WebAug 5, 2024 · Delivered adjusted earnings per share (EPS) of $1.87 versus $1.00 one year ago. Full year GAAP EPS was $3.47 vs $5.82 one year ago. Full year adjusted EPS was $6.75 vs $4.55 in the prior year. ... the impact of the growing number of producers of biotechnology research products and related price competition, general economic … paul mitchell iron

CENTRAL TRUST Co Acquires 798 Shares of Bio-Techne Co.

WebApr 10, 2024 · A high-level overview of Bio-Techne Corporation (TECH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp Stock Price History. BIO-TECHNE Corp’s price is currently up 9.48% so far this month. During the month of April, BIO-TECHNE Corp’s stock price has reached a high of $81.24 and a low ... paul mitchell lemon sage lotion discontinued

BIO-TECHNE Share Price - NSQ:TECH Stock Research Stockopedia

Bio-Techne To Acquire Exosome Diagnostics, Inc.

WebMar 3, 2024 · Over the past six months, its share price has underperformed the S&P500 Index by-8.02%. As of the last closing price of $78.24, shares in BIO-TECHNE were … WebConsensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months. Markets data provided … paul mitchell martial artsWebApr 14, 2024 · The biotechnology company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.03). Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%. paul mitchell maverick

"WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp … " - Biotechne share price

Biotechne share price

Bio-Techne (TECH) - Market capitalization

WebApr 6, 2024 · Complete Bio-Techne Corp. stock information by Barron's. View real-time TECH stock price and news, along with industry-best analysis. WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. …

Did you know?

WebApr 10, 2024 · The 12-month stock price forecast is $103.14, which is an increase of 32.57% from the latest price. Price Target. $103.14 (32.57% upside) Analyst Consensus: Buy. Stock Forecasts. News. All; Videos; ... TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 3... 2 … WebView the latest Bio-Techne Corp. (TECH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

WebApr 9, 2024 · The biotechnology company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.03). Bio-Techne had a net margin of 23.38% and a return ... WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bio-Techne Corp’s P/E ratio is 45.86.

WebAug 24, 2024 · BioTechne Corp price-consensus-chart BioTechne Corp Quote And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 1.2%. WebNov 25, 2024 · ViacomCBS Inc.'s (NASDAQ:VIAC) Intrinsic Value Is Potentially 90% Above Its Share Price Feb 3, 2024 Digital Turbine, Inc. (NASDAQ:APPS) Stocks Pounded By …

WebNov 18, 2024 · As of 18 November 2024, the price of Bio-Techne stock ws standing at $337.84 a share. If a 4-for-1 Bio-Techne stock split is performed today, the post-split …

Web2 days ago · The firm has a market cap of $12.24 billion, a PE ratio of 48.32, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne Co. has a 52-week low of $68.00 and a 52-week high of $108.19. The company has a quick ratio of 3.15, a current ratio of 4.40 and a debt-to-equity ratio of 0.11. paul mitchell hair glazeWebApr 14, 2024 · Finally, Royal Bank of Canada dropped their target price on shares of Bio-Techne from $89.00 to $88.00 and set a “sector perform” rating on the stock in a report … paul mitchell merrillville indianaWebApr 10, 2024 · This rating is based on the ratio between the company's share price and the free cash flow per share generated by its activities, based on the past and analysts' estimates for the coming years. The lower the ratio, the better the rating. Yield "Yield" rating is based on the dividend relative to its share price ... paul mitchell mitchWebMarket cap: $11.66 Billion. As of April 2024 Bio-Techne has a market cap of $11.66 Billion . This makes Bio-Techne the world's 1321th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used ... paul mitchell madison alWebBased in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for ... paul mitchell leave in conditionerWebApr 14, 2024 · The company has a market cap of $13.14 billion, a PE ratio of 51.89, a price-to-earnings-growth ratio of 2.47 and a beta of 1.25. The company has a debt-to-equity … paul mitchell mitch matterialWebApr 6, 2024 · According to the issued ratings of 9 analysts in the last year, the consensus rating for Bio-Techne stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for TECH. The average twelve-month price prediction for Bio-Techne is $104.36 with a high price target of $120.00 and a low price target of $88.00. paul mitchell mti